Close

Epizyme (EPZM), Foundation Medicine Enter Collaboration on Tazemetostat Phase 2 Enrollment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/20/2024

1. NFLX
2. TSM
3. ISRG
4. TSLA
5. INFY
6. SNV
7. SPY
8. SMCI
9. PPG
10. JWN


Go back to Epizyme (EPZM), Foundation Medicine Enter Collaboration on Tazemetostat Phase 2 Enrollment
EPIZYME (NASDAQ: EPZM) Delayed: 1.47 --0 (-0%)
Previous Close $1.47    52 Week High $18.29 
Open $1.47    52 Week Low $7.02 
Day High $1.47    P/E N/A 
Day Low $1.47    EPS $-0.03 
Volume 5,126,122